Asia Pacific Gastrointestinal Drugs Market to Grow at a CAGR of 5.6% to reach US$ 13,618.35 Million from 2020 to 2027
Pharmaceuticals Asia Pacific Gastrointestinal Drugs...

Asia Pacific Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, and Others); Route of Administration (Oral, and Parenteral); Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, and Others); and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country

Publication Month: Nov 2020 | Report Code: TIPRE00016279 | No. of Pages: 147 | Category: Pharmaceuticals | Status: Published
Covid

The Asia Pacific gastrointestinal drugs market is expected to reach US$ 13,618.35 million by 2027 from US$ 8,868.44 million in 2019; it is estimated to grow at a CAGR of 5.6% from 2020 to 2027.

Rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics are the key factors driving the growth of gastrointestinal drugs. However, side effects associated with the drugs is the major factor hindering the market growth in Asia Pacific.

 

Gastrointestinal (GI) disorders are the medical conditions related to the digestive system that affect the colon, small and large intestine, and rectum. The disorders include constipation, irritable bowel, ulcerative colitis, and peptic ulcer diseases. These disorders are characterized by various symptoms such as pain, bloating, diarrhoea, nausea, and vomiting. These disorders constitute a large proportion of outpatients and frequent hospital visits. A wide range of GI drugs is commercially available in the market for the treatment of various conditions. Additionally, rising investments in the development of biologics and the emergence of a biosimilar are expected to drive the growth of the market in the forecast period.

Growing prevalence of IBD can be ascribed to poor nutritional choices, including a high intake of ultra-processed foods and trans-fats. Several studies have highlighted the accelerated growth of gastrointestinal diseases in Asian populations during the past two decades. Both incidence and prevalence rates have shown a notable rise, with scientists pointing out that GI diseases are increasingly the cause of morbidity and mortality in Asian countries. In the World Cancer Research Fund’s annual ranking of the top 20 countries with the highest incidence of stomach cancer, Korea (42 per 100,000), Japan (30 per 100,000), and China (23 per 100,000) ranked as 1st, 3rd, and 5th respectively.

Gastrointestinal (GI) diseases, in particular, are becoming common and have been linked to changing environmental factors brought on by improved sanitation, industrialization, changes in diet, and the increased use of antibiotics. Common GI diseases include ulcerative colitis (UC), colorectal cancer, gastroesophageal reflux disease, inflammatory bowel disease (IBD), and Crohn’s disease (CD). Due to these factors, medical device companies in the GI space have been expanding their business operations in Asia. The incidence and prevalence of many GI disorders are highest amongst the very young and the elderly. As the population ages, the disease burden is expected to grow. The incidence and prevalence of IBD have increased in the last few decades. As per the International Foundation for Gastrointestinal Disorders, Inc., IBD is the most common functional GI disorder with a prevalence rate of 10–15%. Also, it is one of the most common conditions for a visit to a doctor.

 

Countries in the Asia Pacific are facing challenges due to increasing incidences of COVID-19. The outbreak has severely affected the tourism industry and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission. All these factors will impact gastrointestinal drug market for short period of time due to restrictions on supply chain as well as limited manufacturing capabilities. However, in long run the market has strong potential to boost the growth rate as Asia Pacific is most populated region in the world and one of the strong consumers of over the counter generic medications including gastrointestinal disorder drug products.

                                                                            

Rest of Asia Pacific Gastrointestinal drugs Market, Revenue and Forecast to 2027 (US$ Mn)

         Rest of Asia Pacific Gastrointestinal drugs Market, Revenue and Forecast to 2027 (US$ Mn)

Get more information on this report :

ASIA PACIFIC GASTROINTESTINAL DRUGS MARKET SEGMENTATION

 

By Drug Class

  • Acid Neutralizers
  • Antidiarrheal and Laxatives
  • Anti-Inflammatory Drugs
  • Antiemetic and Antinauseants
  • Biologics
  • Others

 

By Route of Administration

  • Oral
  • Parenteral

 

By Application

  • Inflammatory Ulcerative Colitis
  • Crohn's Disease
  • Irritable Bowel Syndrome
  • Gastroenteritis
  • Celiac Disease
  • Others

 

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

 

By Country

  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Rest of APAC

 

Company Profiles

  • Johnson and Johnson Services, Inc.
  • GlaxoSmithKline plc
  • Celltrion Healthcare Co., Ltd.
  • AstraZeneca
  • Takeda Pharmaceutical Company Limited

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Asia Pacific Gastrointestinal Drugs Market – By Drug Class

1.3.2        Asia Pacific Gastrointestinal Drugs Market – By Route of Administration

1.3.3        Asia Pacific Gastrointestinal Drugs Market – By Application

1.3.4        Asia Pacific Gastrointestinal drugs Market – By Distribution Channel

1.3.5        Asia Pacific Gastrointestinal drugs Market – By Country

2.          Asia Pacific Gastrointestinal Drugs Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Asia Pacific Gastrointestinal Drugs Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Gastrointestinal Drugs Market - Asia Pacific PEST Analysis

4.3        Expert Opinion

5.          Asia Pacific Gastrointestinal Drugs Market - Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Rise in Prevalence of Gastrointestinal (GI) Diseases

5.1.2        Increase in Development of Biologics

5.2        Market Restraints

5.2.1        Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies

5.3        Market Opportunities

5.3.1        Increasing Investment in Research Activities and Growing Pipeline of GI Candidates

5.4        Future Trends

5.4.1        Emergence of Biosimilars

5.5        Impact Analysis

6.          Gastrointestinal Drugs Market – Asia Pacific Analysis

6.1        Asia Pacific Gastrointestinal Drugs Market Revenue Forecasts and Analysis

7.          Asia Pacific Gastrointestinal Drugs Market Analysis And Forecasts To 2027 – By Drug Class

7.1        Overview

7.2        Asia Pacific Gastrointestinal Drugs Market, By Drug Class 2019 & 2027 (%)

7.2.1        Asia Pacific Gastrointestinal drugs Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

7.3        Acid Neutralizers

7.3.1        Overview

7.3.2        Asia Pacific Acid Neutralizers Market Revenue and Forecast to 2027 (US$ Mn)

7.4        Antidiarrheal and Laxatives

7.4.1        Overview

7.4.2        Asia Pacific Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)

7.5        Anti-Inflammatory Drugs

7.5.1        Overview

7.5.2        Asia Pacific Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

7.6        Antiemetic and Antinauseants

7.6.1        Overview

7.6.2        Asia Pacific Antiemetic and Antinauseants Market Revenue and Forecast to 2027 (US$ Mn)

7.7        Biologics

7.7.1        Overview

7.7.2        Asia Pacific Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

7.8        Others

7.8.1        Overview

7.8.2        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.          Asia Pacific Gastrointestinal Drugs Market Analysis – By Route of Administration

8.1        Overview

8.2        Asia Pacific Gastrointestinal Drugs Market, By Route of Administration 2019-2027 (%)

8.2.1        Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

8.3        Oral

8.3.1        Overview

8.3.2        Asia Pacific Oral Market Revenue and Forecasts to 2027 (US$ Mn)

8.4        Parenteral

8.4.1        Overview

8.4.2        Asia Pacific Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)

9.          Asia Pacific Gastrointestinal Drugs Market Analysis – By Application

9.1        Overview

9.2        Asia Pacific Gastrointestinal Drugs Market, By Application 2019-2027 (%)

9.2.1        Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.3        Inflammatory Ulcerative Colitis

9.3.1        Overview

9.3.2        Asia Pacific Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)

9.4        Crohn's Disease

9.4.1        Overview

9.4.2        Asia Pacific Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

9.5        Irritable Bowel Syndrome

9.5.1        Overview

9.5.2        Asia Pacific Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)

9.6        Gastroenteritis

9.6.1        Overview

9.6.2        Asia Pacific Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)

9.7        Celiac Disease

9.7.1        Overview

9.7.2        Asia Pacific Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)

9.8        Others

9.8.1        Overview

9.8.2        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

10.       Asia Pacific Gastrointestinal Drugs Market Analysis – By Distribution Channel

10.1     Overview

10.2     Asia Pacific Gastrointestinal Drugs Market, By Distribution Channel 2019-2027 (%)

10.2.1     Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3     Hospital Pharmacies

10.3.1     Overview

10.3.2     Asia Pacific Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.4     Retail Pharmacies

10.4.1     Overview

10.4.2     Asia Pacific Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.5     Online Pharmacies

10.5.1     Overview

10.5.2     Asia Pacific Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

11.       Gastrointestinal Drugs Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1     Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts To 2027

11.1.1     Overview

11.1.2     Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)

11.1.3     Asia Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.1.4     Asia Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.1.5     Asia Pacific: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.1.6     Asia Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.7     Asia Pacific: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)

11.1.8     China: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1       China: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2       China: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.1.8.3       China: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.1.8.4       China: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.1.8.5       China: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.9     Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1       Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2       Japan: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.1.9.3       Japan: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.1.9.4       Japan: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.1.9.5       Japan: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.10   India: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1    India: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2    India: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.1.10.3    India: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.1.10.4    India: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.1.10.5    India: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.11   South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.1    South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.2    South Korea: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.1.11.3    South Korea: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.1.11.4    South Korea: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.1.11.5    South Korea: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.12   Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.1    Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.2    Australia: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.1.12.3    Australia: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.1.12.4    Australia: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.1.12.5    Australia: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.13   Rest of Asia-Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.13.1    Rest of Asia-Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.13.2    Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.1.13.3    Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.1.13.4    Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.1.13.5    Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

12.       Impact of COVID-19 Pandemic on Asia Pacific Gastrointestinal Drugs Market

12.1     Asia Pacific: Impact Assessment of COVID-19 Pandemic

13.       Company Profiles

13.1     Takeda Pharmaceutical Company Limited

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2     Celltrion Healthcare Co.,Ltd.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3     GlaxoSmithKline plc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4     AstraZeneca

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5     Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

14.       Appendix

14.1     Glossary of Terms

 


LIST OF TABLES

Table 1.            Asia Pacific Gastrointestinal drugs Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)

Table 2.            Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

Table 3.            Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 4.            Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 5.            Asia Pacific Gastrointestinal Drugs Market, by Drug Class– Revenue and Forecast to 2027 (USD Million)

Table 6.            Asia Pacific Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 7.            Asia Pacific Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 8.            Asia Pacific Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.            China Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 10.         China Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 11.         China Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 12.         China Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.         Japan Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 14.         Japan Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 15.         Japan Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 16.         Japan Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.         India Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 18.         India Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 19.         India Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 20.         India Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.         South Korea Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 22.         South Korea Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 23.         South Korea Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 24.         South Korea Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 25.         Australia Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 26.         Australia Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 27.         Australia Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 28.         Australia Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 29.         Rest of Asia-Pacific Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 30.         Rest of Asia-Pacific Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 31.         Rest of Asia-Pacific Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 32.         Rest of Asia-Pacific Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 33.         Glossary of Terms, Gastrointestinal Drugs Market

 


LIST OF FIGURES

Figure 1.          Gastrointestinal Drugs Market Segmentation

Figure 2.          Asia Pacific Gastrointestinal Drugs Market Overview

Figure 3.          Acid Neutralizers Segment Held Largest Share of Product in Gastrointestinal Drugs Market

Figure 4.          Japan is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.          Asia Pacific Gastrointestinal Drugs Market - Leading Country Markets (US$ Mn)

Figure 6.          Gastrointestinal Drugs Market - Asia Pacific PEST Analysis

Figure 7.          Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint

Figure 8.          Asia Pacific Gastrointestinal Drugs market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.          Asia Pacific Gastrointestinal Drugs Market, By Drug Class 2019 & 2027 (%)

Figure 10.        Asia Pacific Acid Neutralizers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Asia Pacific Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Asia Pacific Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Asia Pacific Antiemetic and Antinauseants Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Asia Pacific Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Asia Pacific Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Asia Pacific Gastrointestinal Drugs Market, by Route of Administration 2019 & 2027 (%)

Figure 17.        Asia Pacific Oral Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Asia Pacific Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Asia Pacific Gastrointestinal Drugs Market, by Application 2019 & 2027 (%)

Figure 20.        Asia Pacific Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Asia Pacific Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Asia Pacific Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        Asia Pacific Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Asia Pacific Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Asia Pacific Gastrointestinal Drugs Market, by Distribution Channel 2019 & 2027 (%)

Figure 27.        Asia Pacific Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.        Asia Pacific Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.        Asia Pacific Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.        Asia Pacific: Gastrointestinal Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 31.        Asia Pacific Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)

Figure 32.        China: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        India: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Rest of Asia-Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Asia Pacific Countries

The List of Companies - Asia Pacific Gastrointestinal Drugs Market

  1. Johnson and Johnson Services, Inc.
  2. GlaxoSmithKline plc
  3. Celltrion Healthcare Co., Ltd.
  4. AstraZeneca
  5. Takeda Pharmaceutical Company Limited
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific gastrointestinal drugs market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific gastrointestinal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00016279
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2020 - The Insight Partners. All rights reserved